Abstract:Both Old World and New World hantaviruses are transmitted through rodents and can lead to hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome in humans without the availability of specific therapeutics. The square-shaped surface spikes of hantaviruses consist of four Gn-Gc heterodimers that are pivotal for viral entry into host cells and serve as targets for the immune system. Previously, a human-derived neutralizing monoclonal antibody, AH100, demonstrated specific neutralization against the Old World hantavirus, Hantaan virus. However, the precise mode binding of this neutralizing monoclonal antibody remains unclear. In the present study, we determined the structure of the Hantaan virus Gn-AH100 antigen-binding fragment complex and identified its epitope. Crystallography revealed that AH100 targeted the epitopes on domain A and b-ribbon and E3-like domain. Epitope mapping onto a model of the higher order (Gn-Gc)4 spike revealed its localization between neighboring Gn protomers, distinguishing this epitope as a unique site compared to the previously reported monoclonal antibodies. This study provides crucial insights into the structural basis of hantavirus neutralizing antibody epitopes, thereby facilitating the development of therapeutic antibodies.IMPORTANCEHantaan virus (HTNV) poses a significant threat to humans by causing hemorrhagic fever with renal syndrome with high mortality rates. In the absence of FDA-approved drugs or vaccines, it is urgent to develop specific therapeutics. Here, we elucidated the epitope of a human-derived neutralizing antibody, AH100, by determining the HTNV glycoprotein Gn-AH100 antigen-binding fragment (Fab) complex structure. Our findings revealed that the epitopes situated on the domain A and b-ribbon and E3-like domain of the HTNV Gn head. By modeling the complex structure in the viral lattice, we propose that AH100 neutralizes the virus by impeding conformational changes of Gn protomer, which is crucial for viral entry. Additionally, sequence analysis of all reported natural isolates indicated the absence of mutations in epitope residues, suggesting the potential neutralization ability of AH100 in diverse isolates. Therefore, our results provide novel insights into the epitope and the molecular basis of AH100 neutralization.

Potent Neutralization Of Hepatitis A Virus Reveals A Receptor Mimic Mechanism And The Receptor Recognition Site

Structural Basis for Neutralization of Hepatitis A Virus Informs a Rational Design of Highly Potent Inhibitors

The Cryo-Em Structure of HAV Bound to a Neutralizing Antibody-F9

Efficient Neutralizing Activity of Cocktailed Recombinant Human Antibodies Against Hepatitis a Virus Infection in Vitro and in Vivo

Structural Basis For The Neutralization And Genotype Specificity Of Hepatitis E Virus

Structural Basis for the Neutralization of Hepatitis E Virus by a Cross-Genotype Antibody

Structural Basis for the Synergetic Neutralization of Hepatitis E Virus by Antibody-Antibody Interaction.

Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1

Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody

Viral Neutralization by Antibody-Imposed Physical Disruption

Generation of Neutralizing and Non-Neutralizing Monoclonal Antibodies Against H7N9 Influenza Virus.

Analysis of Hepatitis E Virus Neutralization Sites Using Monoclonal Antibodies Directed Against a Virus Capsid Protein.

Neutralization Effects of Antibody Elicited by Chimeric HBV S Antigen Viral-Like Particles Presenting HCV Neutralization Epitopes.

Molecular insight into the neutralization mechanism of human-origin monoclonal antibody AH100 against Hantaan virus

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Selection of A Peptide Mimicking Neutralization Epitope of Hepatitis E Virus with Phage Peptide Display Technology

Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection

A Novel Linear Neutralizing Epitope of Hepatitis E Virus

The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis

Bioinspired Artificial Nanodecoys for Hepatitis B Virus.

Spatial Configuration of Hepatitis E Virus Antigenic Domain